
34.44 Delayed Data As of Jan 15 | ![]() Today’s Change | 25.21 Today|||52-Week Range 41.34 | -4.35% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $54.3B |
Takeda Pharmaceutical Co., Ltd. 4-1-1 Dosho-machi Osaka Osaka 540-8645 |
Christophe Weber | President, CEO & Representative Director |
Constantine Saroukos | Chief Financial Officer & Director |
Andrew S. Plump | Director, Research & Development President |
Michael E. Mendelsohn | Chief Medical & Scientific Officer |
Mwana Lugogo | Chief Ethics & Compliance Officer |